GlassScriptPhysician profile
Pouya Hemmati
NPI 1932589850
$168,343.38
in general payments reported to CMS, 2019-2025
26 companies · $96K in 2025
The $96K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $891 · 2020: $1,069 · 2021: $4,666 · 2022: $9,465 · 2023: $6,058 · 2024: $50K · 2025: $96K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $78K · Travel and Lodging: $29K · Education: $24K · Food and Beverage: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $78,000.00 |
| Travel and Lodging | $29,120.61 |
| Education | $23,568.69 |
| Food and Beverage | $19,063.88 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $112,189.76 | 2020-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryosphere Cryoablation System |
| Baxter Healthcare | $25,383.96 | 2024-2025 | Tisseel, Coseal, Floseal |
| Abbott Laboratories | $6,492.63 | 2019-2025 | Epic, Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Piccolo |
| Abiomed | $6,110.93 | 2023-2025 | Impella |
| Zimmer Biomet Holdings, INC. | $3,903.77 | 2024-2025 | Advantagerib, Sternalock Blu System, Sternalock 360 System |
| Edwards Lifesciences Corporation | $3,824.40 | 2021-2025 | Hemosphere, Sapien 3 Ultra Resilia, Pascal |
| Arthrex, INC. | $2,524.00 | 2025 | |
| Becton, Dickinson and Company | $1,517.37 | 2025 | Hemosphere |
| Medtronic, INC. | $1,417.06 | 2021-2025 | Avalus, Corevalve Evolut R, Penditure |
| Bolton Medical INC | $1,130.27 | 2019-2021 | |
| Artivion, INC. | $738.26 | 2022-2023 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Photofix Decellularized Bovine Pericardium |
| Medical Device Business Services, INC. | $581.63 | 2021-2025 | Ethicon, Vistaseal |
| Midsouth Orthopedics INC. | $568.94 | 2025 | |
| Intuitive Surgical, INC. | $484.89 | 2019-2020 | |
| Corcym INC | $312.02 | 2024-2025 | Perceval, Mi Detach - Aortic Cross Clamp - Delivery System Kit |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $225.78 | 2019 | |
| Ethicon US, LLC | $170.63 | 2023-2025 | Vistaseal, Evarrest, Stratafix |
| Lsi Solutions INC | $157.64 | 2024-2025 | Cor-Knot |
| Kerecis Limited | $150.00 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Clearflow INC. | $116.69 | 2024 | Pleuraflow System With Flowglide |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $110.20 | 2024 | |
| Stryker Corporation | $97.62 | 2025 | Na |
| Depuy Synthes Sales INC. | $82.45 | 2024 | Matrixrib, Cranios Reinforced |
| Haemonetics Corporation | $19.79 | 2023 | Teg6s Hemostasis System |
| Boston Scientific Corporation | $17.52 | 2024 | |
| Janssen Pharmaceuticals, INC | $15.17 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pouya Hemmati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.